+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Doxorubicin"

Solid Tumor Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Solid Tumor Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 114 Pages
  • Global
From
North America Non Hodgkin Lymphoma Therapeutics Market Size, Share & Trends Analysis Report By Cell Type (B-Cell Lymphoma and T-Cell Lymphoma), By Therapy Type (Radiation Therapy, Chemotherapy, Targeted Therapy, and Others), By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

North America Non Hodgkin Lymphoma Therapeutics Market Size, Share & Trends Analysis Report By Cell Type (B-Cell Lymphoma and T-Cell Lymphoma), By Therapy Type (Radiation Therapy, Chemotherapy, Targeted Therapy, and Others), By Country and Growth Forecast, 2023 - 2030

  • Report
  • January 2024
  • 101 Pages
  • North America
From
Triple Negative Breast Cancer Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Triple Negative Breast Cancer Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • November 2023
  • 224 Pages
  • Global
Kinenza - Product Thumbnail Image

Kinenza

  • Report
  • October 2018
  • 17 Pages
  • Global
From
Doxorubicin Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Doxorubicin Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Product Type

  • Report
  • September 2023
  • 115 Pages
  • Global
From
Diffuse Large B Cell Lymphoma Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Diffuse Large B Cell Lymphoma Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2024
  • 103 Pages
  • Global
From
Pegylated Liposomal Doxorubicin (PLD) Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Pegylated Liposomal Doxorubicin (PLD) Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • February 2024
  • 95 Pages
  • Global
From
Liposomal Doxorubicin Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Liposomal Doxorubicin Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2023
  • 77 Pages
  • Global
From
Kaposi Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Kaposi Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 94 Pages
  • Global
From
Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 9 - Product Thumbnail Image

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 9

  • Book
  • October 2024
From
Drug Delivery in Cancer - Technologies, Markets & Companies - Product Thumbnail Image

Drug Delivery in Cancer - Technologies, Markets & Companies

  • Report
  • November 2021
  • 747 Pages
  • Global
From
Cytotoxic Drug Market By Drug Type: Global Opportunity Analysis and Industry Forecast, 2024-2033 - Product Thumbnail Image

Cytotoxic Drug Market By Drug Type: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • Report
  • July 2024
  • 245 Pages
  • Global
From
Advanced Drug Delivery Systems in the Management of Cancer - Product Thumbnail Image

Advanced Drug Delivery Systems in the Management of Cancer

  • Book
  • June 2021
Overcoming Cancers Resistant to HER-2 Antibodies. Breaking Tolerance to Antibody-Mediated Immunotherapy Volume 2 - Product Thumbnail Image

Overcoming Cancers Resistant to HER-2 Antibodies. Breaking Tolerance to Antibody-Mediated Immunotherapy Volume 2

  • Book
  • July 2024
  • 250 Pages
Therapeutic Application of Nitric Oxide in Cancer and Inflammatory Disorders - Product Thumbnail Image

Therapeutic Application of Nitric Oxide in Cancer and Inflammatory Disorders

  • Book
  • February 2019
Loading Indicator

Doxorubicin is an oncology drug used to treat a variety of cancers, including leukemia, lymphoma, and breast, ovarian, and bladder cancer. It is a type of anthracycline antibiotic, derived from Streptomyces peucetius, and works by interfering with the growth of cancer cells. It is administered intravenously, and is often used in combination with other drugs. Doxorubicin is one of the most widely used chemotherapy drugs, and is often used in combination with other drugs to treat a variety of cancers. It is also used to treat Kaposi's sarcoma, a type of skin cancer. Side effects of doxorubicin include nausea, vomiting, hair loss, and an increased risk of infection. The doxorubicin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Pfizer, Novartis, Merck, Bristol-Myers Squibb, and AstraZeneca. Show Less Read more